MS is the disease where the S1P mechanism has been most widely studied, but there are ongoing trials to evaluate a similar beneficial effect on other pathological conditions such as rheumatoid arthritis, inflammatory bowel diseases and others some types of cancers. This evidence concerns the gene MBTPS1 and myeloid sarcoma.